RNA Sequencing as a Diagnostic Tool
JAMA · 03.01.2023 · 329 (1) · 85
DOI: 10.1001/jama.2022.22843 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 03.01.2023. Verfasst von Shamika Ketkar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas. Hauptthemen laut MEDLINE: Exome, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: NHGRI NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
This JAMA Insights discusses RNA sequencing, which allows detection of qualitative and quantitative changes in RNA expression across the genome in clinical samples, and how it may improve molecular diagnostic rates achieved by diagnostic exome sequencing and whole-genome sequencing alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
Förderung
- NHGRI NIH HHS
- NIGMS NIH HHS
- NIH HHS
Zitieren
APA
Ketkar, S., Burrage, L. C., & Lee, B. (2023). RNA Sequencing as a Diagnostic Tool. JAMA, 329(1), 85. https://doi.org/10.1001/jama.2022.22843
Vancouver
Ketkar S, Burrage LC, Lee B. RNA Sequencing as a Diagnostic Tool. JAMA. 2023;329(1):85. doi:10.1001/jama.2022.22843
BibTeX
@article{Ketkar2023,
author = {Ketkar, Shamika and Burrage, Lindsay C and Lee, Brendan},
title = {RNA Sequencing as a Diagnostic Tool},
journal = {JAMA},
year = {2023},
volume = {329},
number = {1},
pages = {85},
doi = {10.1001/jama.2022.22843}
}
EUVIMED